Canada· CA-DIN-02548909
WAINUA
A eplontersen product containing eplontersen (eplontersen sodium), registered in Canada by ASTRAZENECA CANADA INC. The same ATC class is registered in 13 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Eplontersen is registered in 13 of 19 countries.
Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 8 of them publish a price we can compare per daily dose
Eplontersen · ATC N07XX21
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- EPLONTERSEN (EPLONTERSEN SODIUM)
- Manufacturer
- ASTRAZENECA CANADA INC
- Country
- Canada (CA)
- ATC code
- N07XX21
- ATC class
- Eplontersen
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eplontersen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesWAINUAAstraZeneca Pharmaceuticals LP
- SpainWAINZUA 45 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAAstrazeneca Ab
- FinlandWainzuaAstraZeneca AB
- SwitzerlandWAINZUA, InjektionslösungAstraZeneca AG
- NetherlandsWainzua 45 mg oplossing voor injectie in een voorgevulde penAstraZeneca AB
- PolandWainzuaAstraZeneca AB
- United KingdomWainzua 45mg/0.8ml solution for injection pre-filled pensAstraZeneca UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea791ddc-f7b4-439f-818e-c1e5926f83d6 GET /v1/drugs/ea791ddc-f7b4-439f-818e-c1e5926f83d6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02548909",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "N07XX21",
"schedule": [
"Prescription"
],
"drug_code": "103775",
"strengths": [
"45 MG"
],
"ahfs_class": null,
"substances": [
"EPLONTERSEN (EPLONTERSEN SODIUM)"
],
"product_categorization": null
}See everything about eplontersen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.